Colony Group, LLC

SEC CIK: 0001542153
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Colony Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overview All 13F holders of RARE Full Q2 2026 holdings

Shares (Q2 2026): 25,157
Value: $840.0K
% of portfolio: <0.1%
Quarters held: 2; Since Q3 2024

Holdings of RARE by Colony Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	25,157	$840.0K	<0.1%	+25,157	New	Holders
Q4 2024	0	$0	0.0%	−5,005−100.0%	Sold out	Holders
Q3 2024	5,005	$278.0K	<0.1%	+5,005	New	Holders